Insulin reduces plasma arginase activity in type 2 diabetic patients

Diabetes Care

Volumn 31, Issue 1, 2008, Pages 134-139

  Kashyap, Sangeeta R ^a,c   Lara, Abigail ^a   Zhang, Renliang ^a   Young, Mi Park ^a   DeFronzo, Ralph A ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE; INSULIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; UREA; VASCULAR CELL ADHESION MOLECULE 1; ARGININE; CARBON; ISOENZYME;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; HYPERINSULINEMIA; INSULIN RESISTANCE; MALE; MUSCLE BIOPSY; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; TANDEM MASS SPECTROMETRY; BLOOD; ENZYMOLOGY; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE TEST; METABOLISM; MIDDLE AGED; REFERENCE VALUE;

ADULT; ARGINASE; ARGININE; BLOOD GLUCOSE; CARBON RADIOISOTOPES; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; ISOENZYMES; MALE; MIDDLE AGED; REFERENCE VALUES;

EID: 38149109904     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc07-1198     Document Type: Article

References (36)

1. Dandona P, Aljada A, Chaudhuri A, Bandyopadhyay A: The potential influence of inflammation and insulin resistance on the pathogenesis and treatment of atherosclerosis-related complications in type 2 diabetes. J Clin Endocrinol Metab 88:2422-2429, 2003
2. Perseghin G, Petersen K, Shulman GI: Cellular mechanism of insulin resistance: potential links with inflammation. Int J Obes Rela Metab Disord 27 (Suppl. 3):S6-S11, 2003
3. Rask-Madsen C, King GL: Mechanisms of disease: endothelial dysfunction in insulin resistance and diabetes. Nature Clin Pract Endocrinolog Metab 3:46-56, 2007
4. Laakso M, Edelman SV, Brechtel G, Baron AD: Decreased effect of insulin to stimulate skeletal muscle flow in obese men. J Clin Invest 85:1844-1852, 1990
5. Cook S, Scherrer U: Insulin resistance, a new target for nitric oxide delivery drugs. Fundam Clin Pharmacol 16:441-453, 2002
6. Kapur S, Bedard S, Marcotte B, Cote CH, Marette A: Expression of nitric oxide synthase I skeletal muscle: a novel role for nitric oxide as a modulator of insulin action. Diabetes 46:1691-1700, 1997
7. Steinberg HO, Brechtel G, Johnson A, Fineberg N, Baron AD: Insulin-mediated skeletal muscle vasodilation: a novel action of insulin to increase nitric oxide release. J Clin Invest 94:1172-1179, 1994
8. Anderson EA, Hoffman RP, Balon TW, Sinkey CA, Mark AL: Hyperinsulinemia produces both sympathetic nueral activation and vasodilatation in normal humans. J Clin Invest 87:2246-2252, 1991
9. Roy D, Perreault M, Marette A: Insulin stimulation of glucose uptake in skeletal muscles and adipose tissues in vivo is NO dependent. Am J Physiol Endocrinol Metabol 274:E692-E699, 1998
10. Xia Y, Dawson V, Dawson T, Snyder S, Zweier J: Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. Proc Natl Acad Sci U S A 93:6770-6774, 1996
11. Williams IL, Wheatcroft SB, Shah AM, Kearney MT Obesity, atherosclerosis and the vascular endothelium: mechanisms of reduced nitric oxide bioavailability in obese humans. Int J Obes 26:754-764, 2002
12. Stuhlinger MC, Abbasi F, Chu JW, Lamendola C, McLaughlin TL, Cooke JP, Reaven GM, Tsao PS: Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor. JAMA 287:1420-1426, 2002
13. Kashyap S, Roman LJ, McLain J, Masters BS, Belfort R, Berria R, Suraamornkul S, Kellogg DL, Liu Y, Belfort R, Berria R, Mandarino L, DeFronzo RA: Insulin resistance in type 2 diabetes is characterized by impaired NOS activity in skeletal muscle. J Clin Endocrinol Metab 90:1100-1105, 2005
14. Lin KY, Ito A, Assagami T, Tsao PS, Adimoolam S, Kimoto M, Tsuji H, Reaven GM, Cooke JP: Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethyarginine dimethylaminohydrolase. Circulation 106:987-992, 2002
15. Zhang C, Hein TW, Chang C, Kuo L: Constitutive expression of arginase in microvascular endothelial cells counteracts nitric oxide-mediated vasodilatory function. FASEB 15:164-1266, 2001
16. Cederbaum SD, Yu H, Grody WW, Kern RM, Yoo P, Iyer RK: Arginases I and II: do their function overlap? Mol Genet Metab 81 (Suppl. 1):S38-S44, 2004
17. Morris CR, Kato GJ, Poljakovic M, Wang X, Blackwelder WC, Sachdev V, Hazen SL, Vichinsky EP, Morris SM, Gladwin MT: Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease. JAMA 294:81-90, 2005
18. Xu W, Kaneko FT, Zheng S, Comhair SA, Janocha AJ, Goggans T, Thunnissen FB, Farver C, Hazen SL, Jennings C, Dweik RA, Arroliga AC, Erzurum SC: Increased arginase II and decreased NO synthesis in endothelial cells of patients with pulmonary arterial hypertension. FASEB 18:1746-1748, 2004
19. Boger RH, Ron ES: L-arginine improves vascular function by overcoming the deleterious effects of ADMA, a novel cardiovascular risk factor. Altern Med 10:14-23, 2005
20. Ervin RB, Wright JD, Reed-Gilette D: Prevalence of leading types of dietary supplements used in the Third National Health and Nutrition Examination Survey, 1988-1994. Adv Data 349:1-7, 2004
21. Schuman SP, Becker SC, Kass DA, Champio HC, Terrin ML, Forman S, Ernst KV, Kelemen MD, Townsend SN, Capriotti A, Hare JM, Gerstenblith G: L-arginine therapy in acute myocardial infarction. JAMA 295:8-64, 2006
22. Russell AS, Ruegg UT: Arginase production by peritoneal macrophages: a new assay. J Immunol Methods 32:375-382, 1980
23. Loscalzo J: What we know and don't know about L-arginine and NO. Circulation 101:2126-2129, 2000
24. Loscalzo J: Adverse effects of supplemental L-arginine in atherosclerosis. Arterioscler Thromb Basc Biol 23:3-5, 2003
25. Chen J, Kuhlencordt P, Urano F, Ichinose H, Astern J, Huang PL: Effects of chronic treatment with L-arginine on atherosclerosis in apoE knockout and apoE/inducible NO synthase double-knout mice. Arterioscler Thromb Vasc Biol 23:97-103, 2003
26. Torres SH, De Sanctis JB, de L Briceno M, Hernandez N, Finol HJ: Inflammation and nitric oxide production in skeletal muscle of type 2 diabetic patients. J Endocrinol 181:419-427, 2004
27. Nisoli E, Clementi E, Carruba MO, Moncada S: Defective mitochondrial biogenesis: a hallmark of the high cardiovascular risk in the metabolic syndrome? Circ Res 100:795-806, 2007
28. Lee J, Ryu H, Ferrante RJ, Morris SM, Ratan RR: Translational control of inducible nitric oxide synthase expression by arginine can explain the arginine paradox. Proc Natl Acad Sci U S A 1004843-4848, 2003
29. Hsueh WA, Law RF: Insulin signaling in the arterial wall. Am J Cardiol 84:21J-24J, 1999
30. Cusi K, Maezono K, Osman A, Pendergrass M, Patti M, Pratipanawatr T, DeFronzo RA, Kahn CR, Mandarino LJ: Insulin resistance differentially affects the PI3-kinase and MAP kinase-mediated signaling in human muscle. J Clin Invest 105:311-320, 2000
31. Fulton D, Gratton J-P, McCabe TJ, Fontana J, Fujio Y, Walsh K, Franke TF, Papapetropoulos A, Sessa WC: Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 399:597-601, 1999
32. Zeng G, Quon MJ: Insulin-stimulated production of nitric oxide is inhibited by wortmannin: direct measurement in vascular endothelial cells. J Clin Invest 98:894-898, 1996
33. Du XL, Edelstein D, Dimmeler S, Ju Q, Sui C, Brownless N: Hyperglycemia inhibits endothelial nitric oxide synthase activity by post translational modification at the Akt site. J Clin Invest 108:1341-1348, 2001
34. Morris SM Jr: Regulation of enzymes of the urea cycle and arginine metabolism. Annu Rev Nutr 22:87-105, 2002
35. Ishii N, Ikenaga H, Carmines PK, Aoki Y, Ogawa Z, Saruta T, Suga T: High glucose augments arginase activity and nitric oxide production in the renal cortex. Metabolism 53:868-874, 2004
36. Ming X, Barandier C, Viswambharan H, Kwak BR, Mach F, Mazzolai L, Hayoz D, Ruffieux J, Rusconi S, Montavi JP, Yang Z: Thrombin stimulates human endothelial arginase activity via RhoA/ROCK pathway. Circulation 110:3708-3714, 2004